scorecard

You Searched For "pfizer stock price" and got 20 results


Sort By:


Business Insider Latest Story Image
4 mins read

Meet Jeff Smith, the hedge-fund investor taking on Pfizer

Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate Ameri…

Alex Morrell   


Business Insider Latest Story Image
5 mins read

Tesla's earnings report will include refocusing on its car business, and it comes as competition heats up

GM's recent success puts pressure on Tesla as it fights to maintain its EV dominance ahead of today…

Dan DeFrancesco   


Business Insider Latest Story Image
2 mins read

Wall Street says buy stocks that pay dividends with $6 trillion of cash ready to be deployed

"We see more opportunities within equities for investors searching for yield," Bank of America's Sa…

Matthew Fox   


Business Insider Latest Story Image
1 min read

This overlooked obesity-drug stock has 80% upside, JPMorgan says

JPMorgan said it expects Structure Therapeutics' oral GLP-1 weight loss drug candidate to generate …

Matthew Fox   


Business Insider Latest Story Image
2 mins read

Stock market today: futures drop after Starbucks and McDonald's misses

US stock futures slid on Wednesday as Amazon's evidence of strong AI demand was tempered by signs o…

Theron Mohamed   


Business Insider Latest Story Image
1 min read

Retail traders have been ditching the Magnificent 7 for pharma stocks like Eli Lilly, says JPMorgan

Nividia is still a retail darling, but last week saw individual investors pivot to names like Eli L…

Yuheng Zhan   


Business Insider Latest Story Image
4 mins read

Sensex, Nifty50 flat in morning trade: HDFC twins, Maruti Suzuki amongst top losers

India’s benchmark indices Sensex and Nifty50 were flat in morning trade on Tuesday amidst positive …

Business Insider Latest Story Image
1 min read

Arena Pharmaceuticals soars 97% as Pfizer to spend $6.7 billion to buy ulcerative colitis drug developer

Arena's stock surge comes after the price this year had dropped by 35%.

Carla Mozée   


Business Insider Latest Story Image
2 mins read

Pfizer and BioNTech surge after the FDA officially approves its COVID-19 vaccine

The vaccine will be marketed under the brand name Comirnaty, and the FDA hopes the approval will nu…

Matthew Fox   


Business Insider Latest Story Image
5 mins read

Interest rates staying where they are is a forgone conclusion, but the Fed's decision day still matters

A September rate cut would come shortly before another major economic event: the US presidential el…

Dan DeFrancesco   


Business Insider Latest Story Image
1 min read

Pfizer extends 5-day gain to record territory as US recommends COVID-19 booster shot

Pfizer cleared a massive resistance level last week when it surged above its record high of $47.39 …

Matthew Fox   


Business Insider Latest Story Image
1 min read

Trillium Therapeutics soars 200% after Pfizer inks deal to buy cancer-drug company for $2.3 billion

Pfizer had originally invested $25 million in Trillium in September of last year, as part of its br…

Matthew Fox   


Business Insider Latest Story Image
1 min read

Pfizer jumps 6% to eclipse record high reached in 1999 as strength from COVID-19 vaccine continues

Shares of Pfizer jumped to a high of $48.57 on Tuesday, more than a dollar higher than its previous…

Matthew Fox   


Business Insider Latest Story Image
3 mins read

Pfizer agrees to buy Seagen for $43 billion

The agreement is an early sign that, despite the threat of close antitrust examinations and higher …

ANI   


Business Insider Latest Story Image
1 min read

Moderna and Pfizer rebound after FDA authorizes third COVID-19 booster shot for immunocompromised

Year-to-date, shares of BioNTech, Moderna, and Pfizer have surged 357%, 275%, and 28%, respectively.

Matthew Fox   


Business Insider Latest Story Image
2 mins read

Moderna, BioNTech tumble 19% amid report the EU is looking into COVID vaccine side effects

The EU's drug regulator is looking at reports about skin rash and kidney problems.

Carla Mozée   


Business Insider Latest Story Image
1 min read

Moderna and Pfizer shares climb after CDC calls for pause in use of J&J COVID-19 vaccine

The CDC's guidance to pause the use of J&J's COVID vaccine came following reports of 6 rare blood c…

Matthew Fox   


Business Insider Latest Story Image
1 min read

BioNTech rallies 16% after boosting the sales forecast for its COVID-19 vaccine and projecting sturdy demand ahead

Vaccine demand is likely to persist well into next year, the company said, with more than a billion…

Ethan Wu   


Business Insider Latest Story Image
1 min read

Moderna and BioNTech stocks are surging amid reports of FDA vaccine-approval progress

Moderna and BioNTech have climbed in recent weeks as the resurgent Delta variant has captured headl…

Ethan Wu   


Business Insider Latest Story Image
2 mins read

Pfizer falls 2% as FDA nears final authorization of its COVID-19 vaccine

Regulators are now working "rapidly" to finalize authorization of Pfizer's shot, FDA Commissioner S…

Ben Winck